130 related articles for article (PubMed ID: 33805342)
1. Bombesin-Tethered Reactive Oxygen Species (ROS)-Responsive Nanoparticles for Monomethyl Auristatin F (MMAF) Delivery.
Kim J; Kim JS; Min KH; Kim YH; Chen X
Bioengineering (Basel); 2021 Mar; 8(4):. PubMed ID: 33805342
[TBL] [Abstract][Full Text] [Related]
2. Polymer-DNA assembled nanoflower for targeted delivery of dolastatin-derived microtubule inhibitors.
Wu T; Shi Y; Yang T; Zhao P; Yang Z; Yang B
RSC Adv; 2024 Mar; 14(14):9602-9608. PubMed ID: 38516154
[TBL] [Abstract][Full Text] [Related]
3. Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity.
Doronina SO; Mendelsohn BA; Bovee TD; Cerveny CG; Alley SC; Meyer DL; Oflazoglu E; Toki BE; Sanderson RJ; Zabinski RF; Wahl AF; Senter PD
Bioconjug Chem; 2006; 17(1):114-24. PubMed ID: 16417259
[TBL] [Abstract][Full Text] [Related]
4. Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell Permeability.
Hingorani DV; Doan MK; Camargo MF; Aguilera J; Song SM; Pizzo D; Scanderbeg DJ; Cohen EEW; Lowy AM; Adams SR; Advani SJ
Mol Cancer Ther; 2020 Jan; 19(1):157-167. PubMed ID: 31597712
[TBL] [Abstract][Full Text] [Related]
5. Discovery and Development of Dolastatin 10-Derived Antibody Drug Conjugate Anticancer Drugs.
Singh SB
J Nat Prod; 2022 Mar; 85(3):666-687. PubMed ID: 35072477
[TBL] [Abstract][Full Text] [Related]
6. A reactive oxygen species-responsive prodrug micelle with efficient cellular uptake and excellent bioavailability.
Xu L; Yang Y; Zhao M; Gao W; Zhang H; Li S; He B; Pu Y
J Mater Chem B; 2018 Feb; 6(7):1076-1084. PubMed ID: 32254295
[TBL] [Abstract][Full Text] [Related]
7. Targeted Drug Delivery with an Integrin-Binding Knottin-Fc-MMAF Conjugate Produced by Cell-Free Protein Synthesis.
Currier NV; Ackerman SE; Kintzing JR; Chen R; Filsinger Interrante M; Steiner A; Sato AK; Cochran JR
Mol Cancer Ther; 2016 Jun; 15(6):1291-300. PubMed ID: 27197305
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and bioactivity evaluation of novel monomethyl auristatin F analogues.
Yang L; Li X; Zhao L; Hu W; Qian Y
Mol Divers; 2024 May; ():. PubMed ID: 38762686
[TBL] [Abstract][Full Text] [Related]
9. Gastrin-releasing peptide receptor-targeted gadolinium oxide-based multifunctional nanoparticles for dual magnetic resonance/fluorescent molecular imaging of prostate cancer.
Cui D; Lu X; Yan C; Liu X; Hou M; Xia Q; Xu Y; Liu R
Int J Nanomedicine; 2017; 12():6787-6797. PubMed ID: 28979118
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal trafficking and cysteine protease metabolism confer target-specific cytotoxicity by peptide-linked anti-CD30-auristatin conjugates.
Sutherland MS; Sanderson RJ; Gordon KA; Andreyka J; Cerveny CG; Yu C; Lewis TS; Meyer DL; Zabinski RF; Doronina SO; Senter PD; Law CL; Wahl AF
J Biol Chem; 2006 Apr; 281(15):10540-7. PubMed ID: 16484228
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
[TBL] [Abstract][Full Text] [Related]
12. Targeted Delivery of Auristatin-Modified Toxins to Pancreatic Cancer Using Aptamers.
Kratschmer C; Levy M
Mol Ther Nucleic Acids; 2018 Mar; 10():227-236. PubMed ID: 29499935
[TBL] [Abstract][Full Text] [Related]
13. EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma.
Capone E; Lamolinara A; D'Agostino D; Rossi C; De Laurenzi V; Iezzi M; Iacobelli S; Sala G
J Control Release; 2018 May; 277():48-56. PubMed ID: 29550398
[TBL] [Abstract][Full Text] [Related]
14. Cyclic RGD-Peptide-Functionalized Polylipopeptide Micelles for Enhanced Loading and Targeted Delivery of Monomethyl Auristatin E.
Qiu M; Wang X; Sun H; Zhang J; Deng C; Zhong Z
Mol Pharm; 2018 Nov; 15(11):4854-4861. PubMed ID: 30259747
[TBL] [Abstract][Full Text] [Related]
15. Improved efficacy of alphavbeta3-targeted albumin conjugates by conjugation of a novel auristatin derivative.
Temming K; Meyer DL; Zabinski R; Senter PD; Poelstra K; Molema G; Kok RJ
Mol Pharm; 2007; 4(5):686-94. PubMed ID: 17683157
[TBL] [Abstract][Full Text] [Related]
16. Novel peptide linkers for highly potent antibody-auristatin conjugate.
Doronina SO; Bovee TD; Meyer DW; Miyamoto JB; Anderson ME; Morris-Tilden CA; Senter PD
Bioconjug Chem; 2008 Oct; 19(10):1960-3. PubMed ID: 18803412
[TBL] [Abstract][Full Text] [Related]
17. Gold nanorods-bombesin conjugate as a potential targeted imaging agent for detection of breast cancer.
Heidari Z; Sariri R; Salouti M
J Photochem Photobiol B; 2014 Jan; 130():40-6. PubMed ID: 24300991
[TBL] [Abstract][Full Text] [Related]
18. New insight on the structural features of the cytotoxic auristatins MMAE and MMAF revealed by combined NMR spectroscopy and quantum chemical modelling.
Johansson MP; Maaheimo H; Ekholm FS
Sci Rep; 2017 Nov; 7(1):15920. PubMed ID: 29162861
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy.
Cho H; Shim MK; Moon Y; Song S; Kim J; Choi J; Kim J; Lee Y; Park JY; Kim Y; Ahn CH; Kim MR; Yoon HY; Kim K
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297566
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and Metabolism Studies of Monomethyl Auristatin F via Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometry.
Park MH; Lee BI; Byeon JJ; Shin SH; Choi J; Park Y; Shin YG
Molecules; 2019 Jul; 24(15):. PubMed ID: 31362431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
